CHIMERIC PROTEIN OF TISSUE FACTOR ACTIVITY INHIBITOR, TFPI AND TFPI-2, AND MUTEIN

PROBLEM TO BE SOLVED: To provide a method of efficiently producing a protein molecule with less glycosylated sites, which has anticoagulant activity at least equal to that of TFPI and other activities when not reinforced, and which reduces immunogenicity of the protein when administered to a mammal....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: INNIS MICHAEL A, CREASEY ALBA A
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:PROBLEM TO BE SOLVED: To provide a method of efficiently producing a protein molecule with less glycosylated sites, which has anticoagulant activity at least equal to that of TFPI and other activities when not reinforced, and which reduces immunogenicity of the protein when administered to a mammal. SOLUTION: The method is to produce chimeric proteins which contain (a) Kunitz-type domain 1 of TFPI-2 and (b) Kunitz-type domain 2 of TFPI, which includes (a) process of providing transformed host cells including expression vectors with polynucleotide sequences encoding the chimeric proteins, further with expression-controlling sequences compatible with expression of the sequences of the polynucleotide sequences encoding the chimeric proteins, and (b) process of incubating the transformed host cells under a condition that the polynucleotide sequences encoding the chimeric proteins can be expressed. COPYRIGHT: (C)2006,JPO&NCIPI